31
May
2022


Share on networks

The multinational technology company Intel has chosen Barcelona to develop a pioneering laboratory for the design of microchips. The company will invest 200 million euros over a period of 10 years, to which the government will add another 200 million euros, with the aim of placing the city at the forefront of the development of these components.

This new laboratory will be located at the Barcelona Supercomputing Center – National Supercomputing Centre (BSC-CNS), where it will open the microprocessor centre facilities. To set up the project, Intel and the government will each contribute 20 million euros a year for the next ten years, and the recruitment of between 250 and 300 workers will begin imminently.

Intel’s decision will place Catalonia at the forefront of innovation in these elements, which have become a key sector for the economy and national competitiveness. The company’s main objective is to reinforce its commitment to zeta-scale computing, a much more powerful technology than the current one.

“Over the last decade, the Barcelona Supercomputing Center and Intel have collaborated on exascale architecture: now they are developing the zeta-scale architecture for the next decade,” the company said in a statement.

Share on networks

Related news

Llum verda a l’ampliació de l’aeroport del Prat: una inversió de 3.200 milions d’euros per assolir els 70 milions de passatgers

News

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona, entre el ‘top cinc’ dels principals hubs de startups de la Unió Europea per segon any consecutiu

News

Barcelona among top five start-up hubs in European Union for second year in a row

El nou Campus Barcelona de Smith+Nephew consolida Catalunya com a referent de la innovació sanitària a Europa

News

New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation

Les ciències de la vida a Catalunya es consoliden com a eix d’innovació i creixement: 220 milions d’inversió i 8,7% del PIB

News

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.